Cape Investment Advisory, Inc. Exelixis, Inc. Call Options Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXEL
# of Institutions
603Shares Held
255MCall Options Held
1.38MPut Options Held
962K-
Black Rock Inc. New York, NY33.5MShares$1.33 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$898 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$591 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$470 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...